Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3',5'-monophosphate (cGMP) in clinical applications : A comparison with a EIA method
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-02-15
著者
-
Sadagopan Nalini
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development
-
Szekely-klepser Gabriella
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development
-
Zhang Yanhua
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development Gr
-
DUFIELD Dawn
Molecular Biology, Pfizer Global Research & Development
-
KLOVER Jon
Molecular Biology, Pfizer Global Research & Development
-
LI Wenlin
Department of Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research & Development
-
LEPSY Christopher
Department of Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research & Development, Groton
-
Lepsy Christopher
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development Gr
-
Dufield Dawn
Molecular Biology Pfizer Global Research & Development
-
Klover Jon
Molecular Biology Pfizer Global Research & Development
-
Li Wenlin
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development
関連論文
- Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3',5'-monophosphate (cGMP) in clinical applications : A comparison with a EIA method
- Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery